22-Nov-24 |
AZN |
JP Morgan Cazenove |
Overweight |
- |
140.00 |
Reiteration |
22-Nov-24 |
GNS |
Shore Capital |
Not Rated |
- |
- |
Reiteration |
HEMO |
1.61p |
+5.2% |
AVCT |
48.41p |
+4.1% |
EAH |
67.80p |
+2.7% |
ONT |
125.10p |
+1.9% |
GUN |
0.12p |
+1.7% |
HIK |
1,897.00p |
+1.3% |
GPL |
0.20p |
+1.3% |
AZN |
10,180.00p |
+1.2% |
HLN |
376.50p |
+1.1% |
GSK |
1,322.50p |
+1.0% |
TCF |
0.52p |
-4.2% |
OVB |
1.65p |
-2.9% |
IXI |
11.69p |
-2.6% |
OXB |
402.50p |
-2.4% |
VAL |
1.64p |
-2.2% |
RGT |
15.67p |
-2.1% |
VRCI |
3.31p |
-2.0% |
FARN |
141.15p |
-0.9% |
ANP |
336.67p |
-0.2% |
Top of Page
You are here:
research